Progress in neuropathology changes the understanding of neurodegenerative diseases;Les progrès en neuropathologie modifient la conception des maladies neurodégénératives

Revue du Praticien

Volumn 63, Issue 5, 2013, Pages 655-661

  Duyckaerts, Charles ^a,b   Seilhean, Danielle ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; IMMUNOHISTOCHEMISTRY; NEUROPATHOLOGY; PARKINSON DISEASE; PRION DISEASE;

AMYLOID BETA-PEPTIDES; ANIMALS; COMPREHENSION; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEURODEGENERATIVE DISEASES; NEUROLOGY; RATS; TAU PROTEINS;

EID: 84878489496     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Glenner GG, Wong CW. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-90. (Pubitemid 14104991)
2. Brion JP, Passareiro H, Nunez J, Flament-Durand J. Mise en évidence immunologique de la protéine Tau au niveau des lésions de dégénérescence neurofibrillaire de la maladie d'Alzheimer. Arch Biol (Brux) 1985;95:229-35. (Pubitemid 15000733)
3. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-7. (Pubitemid 27443610)
4. Maroteaux L, Campanelli JT, Scheller RH. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 1988;8:2804-15.
5. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-72. (Pubitemid 43970103)
6. Calne DB, Mizuno Y. The neuromythology of Parkinson's Disease. Parkinsonism Relat Disord 2004;10:319-22. (Pubitemid 38757814)
7. Luk KC, Kehm V, Carroll J, et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012;338:949-53.
8. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-54.
9. Seilhean D, Le Ber I, Sarazin M, et al. Fronto-temporal lobar degeneration: neuropathology in 60 cases J Neural Transm 2012;118:753-64.
10. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-3. (Pubitemid 44547757)
11. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host Science 2006;313:1781-4. (Pubitemid 44454153)
12. Clavaguera F, Bolmont T, Crowther RA, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009;11:909-13.
13. Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM. Synthetic Tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like Tauopathy. J Neurosci 2013;33:1024-37.